However, certain cancer types (e.g., pancreatic, lung) demonstrate contradicting sensitivity to GLS inhibition in vitro and in vivo, suggesting that tumors may be more glutaminolysis independent in vivo than modeled in culture [39,40]. The gene discussed is GLS; the disease is cancer.